MedTrace Logo

Exploration and Determination of Genomic Markers Predictive of Uterine Atony

NCT03413917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2026-01-26

No results posted yet for this study

Summary

The primary objective of this study is to determine whether there are markers in the tissue of atonic uteri, and in the patients' plasma that would help identify patients likely to suffer postpartum hemorrhage due to uterine atony. We also will attempt to identify the cause(s) of uterine atony that might suggest mechanisms to prevent and manage it.

Conditions

  • Uterine Atony

Interventions

OTHER

Analysis of genomic markers in uterine atony

No intervention will be performed. We will be analyzing tissue and blood samples only to identify potential association of genomic markers with uterine atony.

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Jack Stecher, MD · Baylor Univeristy Medical Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-02
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413917 on ClinicalTrials.gov